Sunday, November 28, 2021

Indian Council of Medical Research

Mixing Covishield, Covaxin provides better immunity: ICMR

The results of a study conducted by ICMR showed that the people in the mix and match group had superior immunogenicity profiles against Alpha, Beta and Delta variants of Covid-19

60 per cent of Telangana’s population have developed antibodies against Covid-19: NIN

The survey was conducted in the districts of Jangaon, Nalgonda and Kamareddy in collaboration with the health department and covered all age groups including children between 6 years and 9 years.

Govt to promote Telangana brand processed fish

Efforts being made to purchase fish directly from the fishermen cooperative societies

All you need to know about Kappa variant of Covid-19

Hyderabad: After the Delta and Delta Plus variants of the Covid-19, a new strain – Kappa – has been discovered and three people infected...

India reports 44,111 new COVID-19 cases, active tally below 5 lakh

With 57,477 recoveries in the last 24 hours, daily recoveries continued to outnumber the daily new cases for the 51st consecutive day.

1.32 lakh Covid cases, 3,207 deaths in India in 24 hrs

On June 1, India reported 1,27,510 cases lowest since April 8. On April 8, India had recorded 1,31,968 cases while on April 7, India witnessed 1,26,789 fresh cases.

India records 1.86L new Covid cases, lowest since April 14

This is for the second time since April 14 that India has recorded less than two lakh cases of Covid

Over 3.26L new Covid cases, 3,890 deaths in India in 24 hrs

In the past 23 days India's daily Covid tally has plateaued over the three-lakh-mark and over 3,000 casualties for 17 days

Telangana asks hospitals to follow standard treatment protocol

Hyderabad: The State government has directed all government and private hospitals in Telangana to adopt and strictly follow standard treatment protocols framed by Indian...

Telangana to double Covid testing

Move vital for State to contain the spread of virus, says Chief Secretary

Covaxin results reflect India’s emergence as vaccine superpower: ICMR DG

Covaxin has been developed on the WHO prequalified vero cell platform, which is globally recognised with a well-established track record of safety

Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 clinical trials

The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council of Medical Research, the Hyderabad-based company said in a statement.

Address vaccination hesitancy

Instances of adverse reactions should be analysed meticulously and shared with the public in an open manner

Expert panel recommends Bharat Biotech’s ‘Covaxin’ for emergency use

The final decision on its approval will, however, be taken by the Drug Controller General of India (DCGI)

Expert panel clears Covishield vaccine’s emergency use in India

The application will be sent to Drugs Controller General of India (DCGI) V.G. Somani for final approval

Latest News

- Advertisement -